CapsoVision

We’re excited to share that CapsoVision will be exhibiting at ESGE DAYS 2026 by European Society of Gastrointestinal Endoscopy (ESGE).

This year in Milan, we look forward to again connecting with leading clinicians and partners to share how we’re continuing to advance capsule endoscopy. At Booth #14, we’ll be highlighting CapsoCam Plus®, our capsule endoscopy system offering a complete 360° panoramic view, along with CapsoCloud and our AI Highlights (For investigational use only).

Our team of experts will be on-site throughout the event and welcome the opportunity to connect.

📅 May 14–16, 2026
📍 Allianz MiCo Milan Convention Centre, Milan
🏢 Booth #14

Learn more: https://capsovision.com

Our 2026 CapsoVision National Sales Meeting, New Frontiers, wrapped up last week in Fort Worth.

Bringing our team together is always a powerful reminder of what drives us: innovation, collaboration, and a shared commitment to empowering patients and providers through capsule endoscopy.

Thank you to everyone who made the week impactful. The energy, ideas, and alignment we’re carrying forward set the tone for what’s ahead.

CapsoVision has announced submission of its 510(k) application to the Food and Drug Administration for its proprietary AI-assisted module for CapsoCam Plus®. The addition of this reading tool will improve the detection of clinically significant pathology, as well as reduce clinician review time.

“This submission marks an important milestone in our commitment to customers and patients towards advancing a best-in-class solution that integrates advanced imaging with AI-powered interpretation for small bowel diagnostics,” said Johnny Wang, President and Chief Executive Officer. “We believe we are the only capsule endoscopy company with in-house AI core competency, and the scale and quality of our growing image data trove create a powerful foundation for training AI models and uncovering new clinical insights that will set our platform apart from competitive options. Combined with our fully cloud-based architecture—which eliminates the need for on-site servers, reduces cost and downtime, and removes the burden of IT maintenance—we are delivering an AI-enabled diagnostic platform designed to bring efficiency, accuracy, and accessibility to GI practices of all sizes.”

Read the full release here: https://investors.capsovision.com/news-releases/news-release-details/capsovision-announces-510k-submission-addition-ai-assisted